Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Acute pancreatitis in a 61-year-old man with COVID-19

Shay Brikman, Veronika Denysova, Husam Menzal and Guy Dori
CMAJ July 27, 2020 192 (30) E858-E859; DOI: https://doi.org/10.1503/cmaj.201029
Shay Brikman
Departments of Internal Medicine E (Corona A) (Brikman, Denysova, Dori) and Surgery B (Menzal), HaEmek Medical Center, Afula, Israel; Faculty of Medicine (Brikman, Dori), Technion — Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronika Denysova
Departments of Internal Medicine E (Corona A) (Brikman, Denysova, Dori) and Surgery B (Menzal), HaEmek Medical Center, Afula, Israel; Faculty of Medicine (Brikman, Dori), Technion — Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Husam Menzal
Departments of Internal Medicine E (Corona A) (Brikman, Denysova, Dori) and Surgery B (Menzal), HaEmek Medical Center, Afula, Israel; Faculty of Medicine (Brikman, Dori), Technion — Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Dori
Departments of Internal Medicine E (Corona A) (Brikman, Denysova, Dori) and Surgery B (Menzal), HaEmek Medical Center, Afula, Israel; Faculty of Medicine (Brikman, Dori), Technion — Israel Institute of Technology, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading
KEY POINTS
  • Acute pancreatitis has been associated with severe coronavirus disease 2019 (COVID-19).

  • Medications used to manage severe COVID-19 have been associated with acute pancreatitis.

  • Unresolved abdominal pain occurring late in the course of COVID-19 warrants a thorough work-up, which may include testing for levels of amylase, lipase, liver enzymes and triglycerides, and abdominal computed tomography.

A 61-year-old previously healthy man who was not taking any medications was admitted to hospital with fever, dyspnea and cough, which he had for 5 days. Our patient had been in close contact with his father, who had confirmed coronavirus disease 2019 (COVID-19). Radiography of his chest showed bilateral opacities compatible with viral pneumonia, and results from testing of nasal and throat swabs using real-time transcription polymerase chain reaction assay were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Within 3 days of our patient’s admission to hospital, severe COVID-19 pneumonia developed,1 with tachypnea and hypoxemia that required high-flow oxygen supplementation, fever and weight loss. We initially prescribed azithromycin (500 mg daily for 3 d), hydroxychloroquine (loading dose of 800 mg on day 1, followed by 200 mg twice daily for 10 d) and zinc (50 mg twice daily for 5 d). In addition, he received acetaminophen as needed (1000 mg on 4 different occasions). We later prescribed tocilizumab (anti-interleukin-6 receptor antibody, 2 doses of 400 mg administered intravenously), dexamethasone (10 mg twice daily administered intravenously for 5 d with tapering thereafter), enoxaparin (80 mg twice daily for 10 d), lopinavir/ritonavir (2 tablets of 200 mg/50 mg twice daily for 5 d) and pantoprazole (40 mg daily administered intravenously). A culture of his sputum identified Staphylococcus aureus, and we added ciprofloxacin (400 mg twice daily administered intravenously) and clindamycin (300 mg administered orally 4 times a day for 7 d). Seven days later, our patient’s respiratory status had improved, and he no longer required high-flow oxygen.

On day 14, our patient reported sudden diffuse abdominal pain with anorexia. He was afebrile and had no vomiting or diarrhea. His abdomen was soft, with mild diffuse tenderness but no signs of peritoneal irritation. A complete blood cell count showed his level of leukocytes was elevated at 37 (normal 4.5–11.5) × 109/L with 93% neutrophils, and he had an absolute lymphocyte count of 0.98 (normal 1.5–5.0) × 109/L. His serum lipase level was elevated at 203 (normal 21–67) U/L, and he had a serum amylase level of 142 U/L (28–100 U/L). His levels of alkaline phosphatase and direct bilirubin were in the normal range. Contrast-enhanced computed tomography (CT) of our patient’s abdomen showed signs of pancreatitis (Figure 1).2 We diagnosed acute pancreatitis and started supportive treatment, including nothing by mouth, intravenous fluids and analgesia.

Figure 1:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1:

Abdominal contrast-enhanced computed tomography in a 61-year-old man recovering from severe coronavirus disease 2019 pneumonia that shows signs of acute pancreatitis, including focal parenchymal enhancement of the pancreas head with inflammatory changes in peripancreatic fat (red arrow).

Two days later, our patient’s gastrointestinal symptoms had resolved completely, and all abnormal laboratory values had returned to normal. We ran additional blood tests to investigate the cause of acute pancreatitis.3 His levels of liver enzymes and calcium were normal. His serum level of triglycerides was mildly elevated (3.18 [normal 1.8] mmol/L; his level was normal [< 1.69 mmol/L] 1 d before the onset of abdominal pain and was 3.46 mmol/L on the day after the contrast-enhanced CT). Imaging did not show gallstones, or abnormalities of the gallbladder or bile duct. Our patient did not have a medical history of pancreatitis, and he had no history of heavy consumption of alcohol.

Discussion

Acute pancreatitis is an inflammatory disorder of the pancreas, most commonly caused by gallstones and heavy alcohol consumption. 4 The revised Atlanta classification system defines acute pancreatitis if at least 2 of the following 3 criteria are met in a patient: abdominal pain (acute onset of persistent and severe epigastric pain); increased serum lipase (or amylase) levels to greater than 3 times the upper limit of normal value; or characteristic findings of acute pancreatitis on contrast enhanced CT.2 Our patient met 2 out of 3 criteria, as his elevated lipase level did not exceed 3 times the upper limit of normal value. We propose that our patient’s acute pancreatitis was most likely related to infection with SARS-CoV-2, medication used to manage the infection or a combination of both.

Up to 10% of acute pancreatitis is thought to have an infectious cause (mostly viral; e.g., mumps, coxsackievirus or cytomegalovirus) either through direct viral injury or through an immune-mediated inflammatory response.5 The SARS-CoV-2 Spike protein binds angiotensin-converting enzyme 2 (ACE2) protein of the host cell membrane to fuse into the cell for viral replication. Angiotensin-converting enzyme-2 is highly expressed on lung alveolar epithelial cells;6 however, overexpression of ACE2 in the pancreas has been reported recently.7

Our patient’s presentation and onset of symptoms is consistent with previous findings that 17% of patients with severe COVID-19 have pancreatic injury with elevated serum amylase and lipase, and as many as 7% of patients have imaging findings compatible with pancreatitis.7,8 A case report involving 3 members of the same family who were admitted to hospital in Denmark found 2 cases of acute pancreatitis associated with COVID-19, both shortly after admission and with plasma levels of amylase over 900 U/L.9 In a letter to the editor of the British Journal of Surgery, Anand and colleagues reported a case involving a 59-year-old woman with COVID-19 in the United Kingdom who had acute pancreatitis 10 days after admission to hospital, which was complicated by bacterial pneumonia. She was treated with intravenous vancomycin and a course of doxycycline.10

Drug-related acute pancreatitis is relatively uncommon, accounting for less than 5% of all cases of acute pancreatitis, with numerous drugs being suggested as causative agents.3,4 During the course of our patient’s disease, he received a combination of at least 4 drugs that have been associated with acute pancreatitis (i.e., acetaminophen, dexamethasone, ciprofloxacin and pantoprazole),3 in addition to tocilizumab, a known causative agent.11 Two recent reports described patients with COVID-19 who developed pancreatitis with hypertriglyceridemia (level of serum triglyceride > 11.3 mmol/L) during treatment with a combination of tocilizumab and lopinavir/ritonavir.12,13

Although case reports cannot establish causality, our patient’s disease trajectory suggests that the manifestations of COVID-19 may include acute pancreatitis. Physicians should consider this possibility early or late in the course of COVID-19 illness.

In addition, using personal protective equipment may compromise the reliability of the physical examination of patients with COVID-19. Thus, unresolved abdominal pain warrants a thorough work-up, including testing for levels of amylase, lipase liver enzymes and triglycerides, and a complete blood cell count as an initial screening. If laboratory results are outside of normal ranges, clinicians may wish to consider further investigation with contrast-enhanced CT.

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

  • The authors have obtained patient consent.

  • Contributors: Shay Brikman conceived the work and wrote the draft. Veronika Denysova, Husam Menzal and Guy Dori analyzed and interpreted the data and revised the manuscript critically for important intellectual content. All of the authors gave final approval of the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

References

  1. ↵
    1. Wu Z,
    2. McGoogan JM
    . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 Feb. 24 [Epub ahead of print]. doi: 10.1001/jama.2020.2648.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Banks PA,
    2. Bollen TL,
    3. Dervenis C,
    4. et al.
    Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis — 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102–11.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Wolfe D,
    2. Kanji S,
    3. Yazdi F,
    4. et al
    . Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations. PLoS One 2020; 15:e0231883.
    OpenUrl
  4. ↵
    1. Forsmark CE,
    2. Vege SS,
    3. Wilcox CM
    . Acute pancreatitis. N Engl J Med 2016;375: 1972–81.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Rawla P,
    2. Bandaru SS,
    3. Vellipuram AR
    . Review of infectious etiology of acute pancreatitis. Gastroenterology Res 2017;10:153–8.
    OpenUrl
  6. ↵
    1. Bourgonje AR,
    2. Abdulle AE,
    3. Timens W,
    4. et al
    . Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020 May 20 [Epub ahead of print]. doi: 10.1002/path.5471.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Liu F,
    2. Long X,
    3. Zhang B,
    4. et al
    . ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 2020 Apr. 22 [Epub ahead of print]. S1542–3565(20)30537–1. doi: 10.1016/j.cgh.2020.04.040.
    OpenUrlCrossRef
  8. ↵
    1. Wang F,
    2. Wang H,
    3. Fan J,
    4. et al
    . Pancreatic injury patterns in patients with COVID-19 pneumonia. Gastroenterology 2020 Apr. 1 [Epub ahead of print]. S0016–5085 (20)30409–1. doi: 10.1053/j.gastro.2020.03.055.
    OpenUrlCrossRef
  9. ↵
    1. Hadi A,
    2. Werge M,
    3. Kristiansen KT,
    4. et al
    . Coronavirus disease-19 (COVID-19) associated with severe acute pancreatitis: case report on three family members. Pancreatology 2020;20:665–7.
    OpenUrl
  10. ↵
    1. Anand ER,
    2. Major C,
    3. Pickering O,
    4. et al
    . Acute pancreatitis in a COVID-19 patient. Br J Surg 2020;107:e182.
    OpenUrl
  11. ↵
    1. Flaig T,
    2. Douros A,
    3. Bronder E,
    4. et al
    . Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System. J Clin Pharm Ther 2016;41:718–21.
    OpenUrl
  12. ↵
    1. Rubel AR,
    2. Chong PL,
    3. Abdullah MS,
    4. et al
    . Lipemic serum in patients with (coronavirus disease 2019) COVID-19 undergoing treatment. J Med Virol 2020 Apr. 28 [Epub ahead of print]. doi: 10.1002/jmv.25942.
    OpenUrlCrossRef
  13. ↵
    1. Morrison AR,
    2. Johnson JM,
    3. Ramesh M,
    4. et al
    . Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab. J Med Virol 2020 Apr. 21 [Epub ahead of print]. doi: 10.1002/jmv.25907.
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (30)
CMAJ
Vol. 192, Issue 30
27 Jul 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Acute pancreatitis in a 61-year-old man with COVID-19
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Acute pancreatitis in a 61-year-old man with COVID-19
Shay Brikman, Veronika Denysova, Husam Menzal, Guy Dori
CMAJ Jul 2020, 192 (30) E858-E859; DOI: 10.1503/cmaj.201029

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Acute pancreatitis in a 61-year-old man with COVID-19
Shay Brikman, Veronika Denysova, Husam Menzal, Guy Dori
CMAJ Jul 2020, 192 (30) E858-E859; DOI: 10.1503/cmaj.201029
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Discussion
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Acute pancreatitis in a patient with COVID-19
  • Google Scholar

More in this TOC Section

  • Chronic cutaneous ulcer from drug use
  • A low-barrier, flexible safe supply program to prevent deaths from overdose
  • Digital gangrene in a woman with scleroderma
Show more Practice

Similar Articles

Collections

  • Sections
    • Cases
  • Topics
    • Critical & intensive care
    • Gastroenterology
    • Imaging
    • Infectious diseases
    • Infectious diseases: COVID-19
    • Internal medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire